“…The D1 subscore has been shown to be the most informative dimension at this stage of the disease to evaluate change with the possibility to predict the loss of walking ability. 17,19,23 D1 subscore explores not only the ability to walk but also the ability to stand and to transfer from standing to sitting, which are interesting functional abilities in this stage of the disease. Although this study should be replicated in a different cohort to improve the robustness of the results, we strongly recommend consideration of MFM as an outcome measure in clinical trials including ambulatory patients with DMD treated with corticosteroids, especially as SRM values of at least 0.8 for the D1 subscore were observed after 6 months of corticosteroid treatment, confirming that this subscore was the most sensitive to change in this population.…”